Company brief: planqc
Information only, not investment advice. This view does not rate, score or recommend any company or investor. Figures are as published by the sources named, with their dates; missing evidence is shown as not covered, never as a low value.
Brief dated 2026-11-04. Figures assembled on 2026-11-04 from the stored copies of the sources named in each section.
Use the print command of your browser to keep this brief as a PDF. Links stay readable in print.
Company and sources
- Country
- Germany
- SME in CORDIS
- Yes
- Technology areas of its EU projects
- Quantum computing and simulation, Enabling technologies and supply chain
Legal entities linked to this company after a review of name and country:
EU grants
Takes part in 3 EU-funded quantum projects. EU contribution received: EUR 2,899,959.50 (net EU contribution CORDIS records for the company in these projects; not the project budgets and not payments).
EIC schemes named by the CORDIS funding scheme
- EIC Accelerator (grant only): 1 project
| Project | EIC scheme | Start | EU contribution to the project |
|---|---|---|---|
| RUBIQON: Crossing the Threshold to Fault-tolerant Digital Neutral Atom Quantum Computing | EIC Accelerator (grant only) | 2026-10-01 | EUR 2,497,281.50 |
| P4Q: Photonics for Quantum Pilot Line | Other scheme | 2026-04-01 | EUR 24,927,964.81 |
| QCFD: Quantum Computational Fluid Dynamics | Other scheme | 2022-11-01 | EUR 4,935,143.25 |
Source: CORDIS, Publications Office of the European Union, retrieved 2026-10-16.
Patent families
2 distinct quantum patent families, looked up on 2026-10-22.
Source: European Patent Office, Open Patent Services, by applicant name in the quantum CPC groups; derived counts only. A count is not a measure of patent quality or ownership.
Publications
Status: not matched in OpenAlex yet.
Source: OpenAlex, CC0; the institution is matched by name and country.
Infrastructure
Status: the deployment tracker names this company in no contract award.
Announced funding rounds
| Date | Type and status | Amount | Investors (organisations) | Sources |
|---|---|---|---|---|
| 2024-07-08 | Series A Closed | EUR 50,000,000 As announced: €50 million in Series-A venture-capital funding | CATRON Holding (lead), DeepTech & Climate Fonds (DTCF) (lead), Bayern Kapital, Max-Planck Foundation, UVC Partners, Speedinvest | Munich Quantum Valley (Ecosystem organisation, read 2026-10-23; Second body paragraph, beginning "As announced today") The round includes a non-dilutive grant of the German Federal Ministry of Education and Research (BMBF); no split is stated. |
| Currency | Total as announced | Rounds |
|---|---|---|
| EUR | EUR 50,000,000 | 1 |
Not added: 0 undisclosed, 0 not closed (targets, commitments and selections), 0 acquisitions or listings and 0 included in a later figure. Currencies are never converted or added together.
From grant to equity
- First EU-funded quantum project
- QCFD, Collaborative research, innovation or coordination action (Horizon Europe), started 2022-11-01; EUR 4,935,143.25 (EU contribution (maximum grant agreed), the whole project). Source: CORDIS.
- First EIC Accelerator project
- RUBIQON, EIC Accelerator (grant only) (Horizon Europe), started 2026-10-01; EUR 2,497,281.50 (EU contribution (maximum grant agreed), the whole project). Source: CORDIS.
- First equity round recorded in the portal
- 2024-07-08, Series A, EUR 50,000,000 (as announced: €50 million in Series-A venture-capital funding). Sources: Munich Quantum Valley (read 2026-10-23; Second body paragraph, beginning "As announced today")
- Time between
- 20 months (1.7 years) from the start of the first project to the first equity round recorded in the portal.
Not covered
- Publications have not been matched in OpenAlex for this company yet.
- Valuations, revenues, ownership stakes, cap tables and individual investors are not collected.
- National grants, regional aid, loans and payments are not covered; EU figures are amounts awarded, not paid.
- Use of infrastructure as a customer is not recorded; only a named supplier role in the deployment tracker is shown.
- Nothing here is a rating, a recommendation or investment advice; figures are as published by their sources.